| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |